Year: 2026
Type: article
Abstract: Bioceramic vehicles for localized drug delivery are well established, but the ceramic sintering temperatures limit the means of drug incorporation and surface-bound drugs are often released rapidly into the surrounding environment. Room-temperature consolidation (RTC) opens a possibility to create bioceramic drug delivery systems, where the drug is distributed within the entire volume of the carrier, potentially achieving higher control over the release profile. In this study, strontium ranelate (SR) containing nanocrystalline hydroxyapatite (nHAp), amorphous calcium phosphate (ACP) and octacalcium phosphate (OCP) bioceramics were produced, using RTC. The low-temperature, high-pressure approach preserved the metastable, low-crystalline calcium phosphates, but minor pressure-induced deterioration of the drug’s ranelic acid residue was present. Ultimately, by varying the consolidation pressure, drug content and calcium phosphate matrix, drug delivery lasting from three to 58 days was achieved.
Source: Scientific Reports
Authors: Linda Dauge(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft), Gustavs Eduards Ernestsons(Formal analysis, Validation), Gints Ernestsons, Janis Locs(Conceptualization, Data curation, Methodology, Project administration, Resources, Supervision, Writing – review & editing)
Institution: Riga Technical University
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7236329597
